Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
7.82
-0.30 (-3.69%)
May 13, 2025, 4:00 PM - Market closed
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 130 employees as of December 31, 2024. The number of employees decreased by 170 or -56.67% compared to the previous year.
Employees
130
Change (1Y)
-170
Growth (1Y)
-56.67%
Revenue / Employee
$1,902,269
Profits / Employee
$306,500
Market Cap
1.06B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AUPH News
- 1 day ago - Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga
- 1 day ago - Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - Business Wire
- 9 days ago - Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - Business Wire
- 14 days ago - Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - Business Wire
- 15 days ago - ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - Business Wire
- 17 days ago - Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth - Seeking Alpha
- 20 days ago - Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting - Business Wire